Marine-Derived Stichloroside C2 Inhibits Epithelial-Mesenchymal Transition and Induces Apoptosis through the

Chuang Cui1,2, Chen-Huan Ding3, Fang-Fang Liu4

  • 1Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China.

Journal of Oncology
|May 24, 2022
PubMed
Abstract

Insights

Sea cucumber saponin stichloroside C2 (STC2) shows potent anti-cancer effects against triple-negative breast cancer (TNBC) by inducing cell death and halting cell division. This study elucidates STC2

Area of Science:

  • Marine Natural Products Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Triterpenoid saponins from sea cucumbers possess known antitumour properties.
  • The specific molecular mechanisms of these compounds remain largely uncharacterized.
  • This study focuses on saponins from *Thelenota ananas*.

Purpose of the Study:

  • To investigate the antitumour activity of triterpenoid saponins isolated from *Thelenota ananas*.
  • To elucidate the underlying molecular mechanisms of action.
  • To evaluate the potential of these compounds as therapeutic agents for triple-negative breast cancer (TNBC).

Main Methods:

  • Isolation and purification of saponins from *Thelenota ananas*.
  • Determination of chemical structures.
  • In vitro functional assays using human (MDA-MB-231) and mouse (4T1) TNBC cell lines.
  • Analysis of apoptosis, cell cycle, DNA damage, and key protein expression levels (e.g., γ-H2AX, cell cycle regulators, EMT markers, MAPK/Akt pathways).

Main Results:

  • Four saponins were identified; stichloroside C2 (STC2) demonstrated significant inhibition of TNBC cell proliferation and clonogenesis.
  • STC2 induced apoptosis and cell cycle arrest in MDA-MB-231 and 4T1 cells.
  • STC2 caused DNA damage, altered expression of cell cycle and apoptosis-related proteins, inhibited epithelial-mesenchymal transition (EMT), and modulated MAPK and Akt signaling pathways.

Conclusions:

  • Stichloroside C2 (STC2) exhibits significant anti-TNBC activity.
  • STC2 functions by inducing apoptosis, regulating the cell cycle, and inhibiting EMT.
  • The compound modulates key signaling pathways including MAPK and Akt, offering a potential therapeutic strategy.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K